China vs Latvia: Death rate from Alzheimer's
China
35.74 deaths per 100,000 people
in 2021
Latvia
34.55 deaths per 100,000 people
in 2021
China rank
37th
Latvia rank
39th
Death rate from Alzheimer's over time
- China
- Latvia
How they compare
China currently reports 35.74 deaths per 100,000 people against 34.55 deaths per 100,000 people in Latvia, a difference of 1.19 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was China ahead.
China ranks 37th and Latvia ranks 39th of 194 countries.
Across the 3 decades both report, China averaged higher in 2 and Latvia in 1.
Head to head by decade
| Decade | China | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.89 deaths per 100,000 people | 5.42 deaths per 100,000 people | 12.48 deaths per 100,000 people | China |
| 2010s | 26.3 deaths per 100,000 people | 16.84 deaths per 100,000 people | 9.46 deaths per 100,000 people | China |
| 2020s | 33.63 deaths per 100,000 people | 34.05 deaths per 100,000 people | 0.42 deaths per 100,000 people | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, China or Latvia?
- China, at 35.74 deaths per 100,000 people against 34.55 deaths per 100,000 people in Latvia as of 2021.
- What is the difference in death rate from alzheimer's between China and Latvia?
- 1.19 deaths per 100,000 people, with China ahead.
- How many years of comparable data are there for China and Latvia?
- 22 years are reported by both, from 2000 to 2021.
- How do China and Latvia rank globally for death rate from alzheimer's?
- China ranks 37th and Latvia ranks 39th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.